Heel Damage, What Comes Next?
Plantar fasciopathy is the most common cause of heel pain — and for many patients, it lingers for months even after doing everything right – rest, orthotics, physical therapy, cortisone injections. When standard care falls short, the typical next step is surgery. But this study asked a different question: what if the tissue itself could be supported before it gets to that point?
Researchers evaluated the use of Wharton’s Jelly (WJ), a collagen-rich connective tissue allograft derived from umbilical cord tissue, as a conservative option for patients with ultrasound-confirmed plantar fascia degeneration who had already exhausted months of conventional treatment.
Study Overview
- Design: Observational study within Regenative Labs’ outcomes repository, IRB-approved (IRCM)
- Participants: 9 patients (mean age 73) with ultrasound-verified plantar fascia degeneration unresponsive to ≥3 months of care
- Intervention: Single ultrasound-guided percutaneous application of a 150 mg Umbilical Cord Tissue (UCT) allograft
Supplementing the Tissue, Not Replacing the Clinician
Umbilical cord tissue (UCT) doesn’t treat or cure disease — it works by supplying a biologically familiar connective tissue tissue to areas where the body’s own tissue has degenerated. Applied under ultrasound guidance, it integrates with the existing structure rather than altering it. For patients at a crossroads between continued conservative care and surgery, that distinction matters.
Study findings suggest UCT allografts may offer a meaningful regenerative medicine-first option — one that supports structure and function at the tissue level before more invasive interventions are considered.
Adding to the Evidence Base
This publication is part of Regenative Labs’ growing body of peer-reviewed research into the homologous, tissue-specific applications of Wharton’s Jelly across musculoskeletal use sites. Each study contributes to a clearer picture of where regenerative connective tissue support fits within the continuum of care — and where the science still needs to go.